80 related articles for article (PubMed ID: 8055697)
21. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of subconjunctival cyclosporin-containing microspheres on keratoplasty rejection in the rabbit.
de Rojas Silva MV; Rodríguez-Ares MT; Sánchez-Salorio M; Lamas Díaz MJ; Cuevas Alvarez J; Vila Jato JL; Capeans Tomé C
Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):840-7. PubMed ID: 10502059
[TBL] [Abstract][Full Text] [Related]
23. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
He X; Johnston A
Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
[TBL] [Abstract][Full Text] [Related]
24. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
25. [The synergistic effect of low-dose cyclosporine and fluocinolone acetonide on the survival of rat allogenic skin graft].
Zhao XF
Zhonghua Wai Ke Za Zhi; 1989 Aug; 27(8):495-7, 510. PubMed ID: 2620608
[TBL] [Abstract][Full Text] [Related]
26. [Combined rapamycin eye drop in nanometer vector and poly (lactic acid) wafers of cyclosporine A effectively prevents high-risk corneal allograft rejection in rabbits].
Jiang W; Sun HM; Li XR; Yuan XB; Wang YQ; Zhang SX; Tian EJ; Yuan JQ
Zhonghua Yan Ke Za Zhi; 2009 Jun; 45(6):550-5. PubMed ID: 19957680
[TBL] [Abstract][Full Text] [Related]
27. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
28. A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.
Baboolal K
Transplantation; 2003 Apr; 75(8):1404-8. PubMed ID: 12717239
[TBL] [Abstract][Full Text] [Related]
29. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
Shi W; Gao H; Xie L; Wang S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
Harrison PC; Mainolfi E; Madwed JB
J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
[TBL] [Abstract][Full Text] [Related]
31. Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix.
Mahlberg K; Uusitalo RJ; Oksala O
Ocul Immunol Inflamm; 1997 Jun; 5(2):101-10. PubMed ID: 9234374
[TBL] [Abstract][Full Text] [Related]
32. The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model.
Claerhout I; Beele H; Verstraete A; Van den Broecke C; Kestelyn P
Graefes Arch Clin Exp Ophthalmol; 2001 Feb; 239(2):152-7. PubMed ID: 11372546
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy of local immunosuppression with intraportal administration of cyclosporine in liver transplantation].
Ko S; Nakajima Y; Kanehiro H; Nakano H
Nihon Geka Gakkai Zasshi; 1995 Mar; 96(3):160-7. PubMed ID: 7731457
[TBL] [Abstract][Full Text] [Related]
34. A subconjunctival degradable implant for cyclosporine delivery in corneal transplant therapy.
Apel A; Oh C; Chiu R; Saville B; Cheng YL; Rootman D
Curr Eye Res; 1995 Aug; 14(8):659-67. PubMed ID: 8529401
[TBL] [Abstract][Full Text] [Related]
35. Survival of rabbit limbal stem cell allografts after administration of cyclosporin A.
Xu KP; Wu Y; Zhou J; Zhang X
Cornea; 1999 Jul; 18(4):459-65. PubMed ID: 10422860
[TBL] [Abstract][Full Text] [Related]
36. The role of systemic cyclosporine dosing schedule on corneal allograft survival in the rat model.
Bouchard CS; Kappil JC; Duffner L
Curr Eye Res; 1995 May; 14(5):421-4. PubMed ID: 7648869
[TBL] [Abstract][Full Text] [Related]
37. Prolongation of heterotopic heart allograft survival by local delivery of continuous low-dose cyclosporine therapy.
Stepkowski SM; Goto S; Ito T; Reynolds K; Didlake R; Kim EK; Kahan BD
Transplantation; 1989 Jan; 47(1):17-23. PubMed ID: 2521407
[TBL] [Abstract][Full Text] [Related]
38. Improved immunosuppression with aerosolized cyclosporine in experimental pulmonary transplantation.
Keenan RJ; Duncan AJ; Yousem SA; Zenati M; Schaper M; Dowling RD; Alarie Y; Burckart GJ; Griffith BP
Transplantation; 1992 Jan; 53(1):20-5. PubMed ID: 1733067
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat.
Juberías JR; Calonge M; Gómez S; López MI; Calvo P; Herreras JM; Alonso MJ
Curr Eye Res; 1998 Jan; 17(1):39-46. PubMed ID: 9472469
[TBL] [Abstract][Full Text] [Related]
40. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.
Milani JK; Pleyer U; Dukes A; Chou HJ; Lutz S; Rückert D; Schmidt KH; Mondino BJ
Ophthalmology; 1993 Jun; 100(6):890-6. PubMed ID: 8510902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
